This is the authors' abstract. We don't add key points for this paper.
Introduction Central Serous Chorioretinopathy (CSC), a leading cause of vision loss, presents diverse treatment challenges based on its acute or chronic manifestation.
No takes yet. Share an insight, caveat, or question.
Borselli et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: